发明名称 |
Anti-TNF antibodies, compositions, methods and uses |
摘要 |
The present invention relates to anti-TNF antibodies comprising all of the heavy chain variable CDR regions of SEQ ID NOS: 1, 2 and 3 and/or all of the light chain variable CDR regions of SEQ ID NOS:4, 5 and 6, specific for at least one human tumor necrosis factor alpha (TNF) protein or fragment thereof, as well as nucleic acids encoding such anti-TNF antibodies, complementary nucleic acids, vectors, host cells, production methods and therapeutic methods. |
申请公布号 |
US9321836(B2) |
申请公布日期 |
2016.04.26 |
申请号 |
US201414068010 |
申请日期 |
2014.02.18 |
申请人 |
Janssen Biotech, Inc. |
发明人 |
Heavner George;Knight David M.;Giles-Komar Jill;Scallon Bernard;Shealy David |
分类号 |
A61K39/395;A61K38/18;A61K38/19;A61K38/27;A61K45/06;C07K16/24;G01N33/53;C07K16/42;G01N33/566;A61K39/00 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
Carey Brian C. |
主权项 |
1. A method for treating a TNF mediated condition, comprising
(a) contacting a sample from a subject with an isolated anti-TNF antibody having a variable region comprising SEQ ID NO:7 or 8; (b) detecting whether TNF is present in said sample; and, if so, (c) administering an effective amount of an isolated anti-TNF antibody having a variable region comprising SEQ ID NO:7 or 8. |
地址 |
Horsham PA US |